- Report
- April 2024
- 124 Pages
Global
From €3590EUR$3,950USD£3,049GBP
- Report
- April 2020
- 120 Pages
Global
From €3327EUR$3,660USD£2,825GBP
- Report
- January 2023
- 220 Pages
Global
From €4045EUR$4,450USD£3,435GBP
- Report
- December 2022
- 122 Pages
North America
From €3136EUR$3,450USD£2,663GBP
- Report
- December 2022
- 137 Pages
Europe
From €3136EUR$3,450USD£2,663GBP
- Report
- December 2022
- 139 Pages
Asia Pacific
From €3136EUR$3,450USD£2,663GBP
- Report
- September 2022
- 202 Pages
Global
From €4045EUR$4,450USD£3,435GBP
- Report
- August 2022
- 236 Pages
From €3136EUR$3,450USD£2,663GBP
- Report
- August 2022
- 245 Pages
North America
From €3136EUR$3,450USD£2,663GBP
- Report
- August 2022
- 258 Pages
Middle East, Africa
From €3136EUR$3,450USD£2,663GBP
- Report
- August 2022
- 273 Pages
Europe
From €3136EUR$3,450USD£2,663GBP
- Report
- August 2022
- 268 Pages
Asia Pacific
From €3136EUR$3,450USD£2,663GBP
- Report
- August 2022
- 110 Pages
Europe
From €3136EUR$3,450USD£2,663GBP
- Report
- August 2022
- 112 Pages
Asia Pacific
From €3136EUR$3,450USD£2,663GBP
- Report
- August 2022
- 89 Pages
From €3136EUR$3,450USD£2,663GBP
- Report
- August 2022
- 102 Pages
North America
From €3136EUR$3,450USD£2,663GBP
- Report
- August 2022
- 96 Pages
Middle East, Africa
From €3136EUR$3,450USD£2,663GBP
- Report
- May 2022
- 347 Pages
Global
From €4045EUR$4,450USD£3,435GBP
- Report
- May 2022
- 152 Pages
Global
From €4045EUR$4,450USD£3,435GBP
- Report
- September 2020
- 130 Pages
Asia Pacific
From €3136EUR$3,450USD£2,663GBP

Asthma is a chronic respiratory condition that affects the airways of the lungs. It is characterized by inflammation, narrowing of the airways, and increased mucus production, which can lead to difficulty breathing, wheezing, and coughing. Asthma is one of the most common chronic diseases in the world, and is a major cause of morbidity and mortality.
The asthma market within the context of pulmonary medicine is a rapidly growing sector, with a wide range of products and services available to treat and manage the condition. These include inhalers, nebulizers, and other devices to deliver medication, as well as monitoring and diagnostic tools. In addition, there are a variety of medications available to treat asthma, including corticosteroids, bronchodilators, and leukotriene modifiers.
Some of the major companies in the asthma market include GlaxoSmithKline, Merck, Novartis, Boehringer Ingelheim, and AstraZeneca. Show Less Read more